A detailed history of Perceptive Advisors LLC transactions in Insmed Inc stock. As of the latest transaction made, Perceptive Advisors LLC holds 702,130 shares of INSM stock, worth $136 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
702,130
Previous 650,252 7.98%
Holding current value
$136 Million
Previous $65.4 Million 54.51%
% of portfolio
0.23%
Previous 2.87%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$96.14 - $147.2 $4.99 Million - $7.64 Million
51,878 Added 7.98%
702,130 $101 Million
Q2 2025

Aug 14, 2025

BUY
$64.81 - $105.9 $9.14 Million - $14.9 Million
140,952 Added 27.68%
650,252 $65.4 Million
Q1 2025

May 15, 2025

BUY
$65.25 - $83.83 $23.8 Million - $30.6 Million
365,300 Added 253.68%
509,300 $38.9 Million
Q4 2024

Feb 14, 2025

SELL
$66.29 - $76.63 $2.39 Million - $2.76 Million
-36,000 Reduced 20.0%
144,000 $9.94 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $3.96 Million - $12.5 Million
180,000 New
180,000 $12.1 Million

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $26.2B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Perceptive Advisors LLC Portfolio

Follow Perceptive Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Perceptive Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Perceptive Advisors LLC with notifications on news.